<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="19964">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01849211</url>
  </required_header>
  <id_info>
    <org_study_id>diffmask</org_study_id>
    <nct_id>NCT01849211</nct_id>
  </id_info>
  <brief_title>Influence of Neuromuscular Block on Mask Ventilation</brief_title>
  <official_title>Influence of a Neuromuscular Block on Face Mask Ventilation Conditions During Induction of Anaesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kreiskrankenhaus Dormagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kreiskrankenhaus Dormagen</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Difficult mask ventilation might lead to a life-threatening situation, if endotracheal
      intubation is also impossible and neuromuscular blocking agents (NMBA) inhibit spontaneous
      ventilation. However, controversies exist if NMBA improve or impede face mask ventilation.
      Therefore, the effect of NMBAs on mask ventilation is assessed in patients with predictors
      for difficult face mask ventilation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label</study_design>
  <primary_outcome>
    <measure>minute volume</measure>
    <time_frame>15 min (from Induction of anaesthesia until onset of NMBA )</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>incidence of difficult mask ventilation  - tidal volume &lt; 150 ml</measure>
    <time_frame>15 min</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>airway pressure</measure>
    <time_frame>15 min</time_frame>
    <safety_issue>No</safety_issue>
    <description>measurement of peak airway pressure</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Effect of a Neuromuscular Block on Ventilation</condition>
  <arm_group>
    <arm_group_label>neuromuscular block</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>rocuronium</intervention_name>
    <arm_group_label>neuromuscular block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with risk factors for difficult face mask ventilation

          -  Patients scheduled for general anaesthesia with endotracheal intubation

        Exclusion Criteria:

          -  Increased Risk for pulmonary aspiration

          -  scheduled for awake fiberoptic intubation

          -  pregnancy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefan Soltesz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>KKH Dormagen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stefan Soltesz, MD</last_name>
    <phone>0049 2133 66 4500</phone>
    <email>stefan.soltesz@kkh-ne.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>KKH Dormagen</name>
      <address>
        <city>Dormagen</city>
        <zip>71375</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Soltesz, MD</last_name>
      <phone>0049 2133 66 4500</phone>
      <email>stefan.soltesz@kkh-ne.de</email>
    </contact>
    <investigator>
      <last_name>Stefan Soltesz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>May 7, 2013</lastchanged_date>
  <firstreceived_date>April 25, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ventilation</keyword>
  <keyword>face mask</keyword>
  <keyword>NMBA</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Rocuronium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
